405 related articles for article (PubMed ID: 9007091)
21. Apolipoprotein E and alpha-1-antichymotrypsin polymorphisms in sporadic inclusion body myositis.
Gossrau G; Gestrich B; Koch R; Wunderlich C; Schröder JM; Schroeder S; Reichmann H; Lampe JB
Eur Neurol; 2004; 51(4):215-20. PubMed ID: 15159602
[TBL] [Abstract][Full Text] [Related]
22. Paired helical filaments of inclusion-body myositis muscle contain RNA and survival motor neuron protein.
Broccolini A; Engel WK; Alvarez RB; Askanas V
Am J Pathol; 2000 Apr; 156(4):1151-5. PubMed ID: 10751338
[TBL] [Abstract][Full Text] [Related]
23. Molecular pathology and pathogenesis of inclusion-body myositis.
Askanas V; Engel WK
Microsc Res Tech; 2005 Jul; 67(3-4):114-20. PubMed ID: 16104000
[TBL] [Abstract][Full Text] [Related]
24. Familial inflammatory inclusion body myositis.
Ranque-Francois B; Maisonobe T; Dion E; Piette JC; Chauveheid MP; Amoura Z; Papo T
Ann Rheum Dis; 2005 Apr; 64(4):634-7. PubMed ID: 15769920
[TBL] [Abstract][Full Text] [Related]
25. New advances in the understanding of sporadic inclusion-body myositis and hereditary inclusion-body myopathies.
Askanas V; Engel WK
Curr Opin Rheumatol; 1995 Nov; 7(6):486-96. PubMed ID: 8579968
[TBL] [Abstract][Full Text] [Related]
26. Nitric oxide stress in sporadic inclusion body myositis muscle fibres: inhibition of inducible nitric oxide synthase prevents interleukin-1β-induced accumulation of β-amyloid and cell death.
Schmidt J; Barthel K; Zschüntzsch J; Muth IE; Swindle EJ; Hombach A; Sehmisch S; Wrede A; Lühder F; Gold R; Dalakas MC
Brain; 2012 Apr; 135(Pt 4):1102-14. PubMed ID: 22436237
[TBL] [Abstract][Full Text] [Related]
27. Ubiquitin expression in inclusion body myositis. An immunohistochemical study.
Albrecht S; Bilbao JM
Arch Pathol Lab Med; 1993 Aug; 117(8):789-93. PubMed ID: 8393651
[TBL] [Abstract][Full Text] [Related]
28. Upregulation of Fas/Fas ligand in inclusion body myositis.
Fyhr IM; Oldfors A
Ann Neurol; 1998 Jan; 43(1):127-30. PubMed ID: 9450780
[TBL] [Abstract][Full Text] [Related]
29. Nitric oxide-induced oxidative stress in autosomal recessive and dominant inclusion-body myopathies.
Yang CC; Alvarez RB; Engel WK; Heller SL; Askanas V
Brain; 1998 Jun; 121 ( Pt 6)():1089-97. PubMed ID: 9648544
[TBL] [Abstract][Full Text] [Related]
30. Idiopathic inflammatory myopathies: inclusion-body myositis, polymyositis, and dermatomyositis.
Askanas V; Engel WK; Mirabella M
Curr Opin Neurol; 1994 Oct; 7(5):448-56. PubMed ID: 7804466
[TBL] [Abstract][Full Text] [Related]
31. Cyclin-dependent kinase 5 colocalizes with phosphorylated tau in human inclusion-body myositis paired-helical filaments and may play a role in tau phosphorylation.
Wilczynski GM; Engel WK; Askanas V
Neurosci Lett; 2000 Oct; 293(1):33-6. PubMed ID: 11065131
[TBL] [Abstract][Full Text] [Related]
32. Redox factor-1 in muscle biopsies of patients with inclusion-body myositis.
Broccolini A; Engel WK; Alvarez RB; Askanas V
Neurosci Lett; 2000 Jun; 287(1):1-4. PubMed ID: 10841976
[TBL] [Abstract][Full Text] [Related]
33. [Significance of rimmed vacuoles in neuromuscular disorders--a comparative immunohistochemical study of inclusion body myositis and distal myopathy with rimmed vacuole formation].
Murakami N; Takemitsu M; Kurashige T; Nonaka I
Rinsho Shinkeigaku; 1994 Aug; 34(8):782-7. PubMed ID: 7994984
[TBL] [Abstract][Full Text] [Related]
34. Use of anti-neurofilament antibody to identify paired-helical filaments in inclusion-body myositis.
Askanas V; Alvarez RB; Mirabella M; Engel WK
Ann Neurol; 1996 Mar; 39(3):389-91. PubMed ID: 8602760
[TBL] [Abstract][Full Text] [Related]
35. Multiple mitochondrial DNA deletions in sporadic inclusion body myositis: a study of 56 patients.
Santorelli FM; Sciacco M; Tanji K; Shanske S; Vu TH; Golzi V; Griggs RC; Mendell JR; Hays AP; Bertorini TE; Pestronk A; Bonilla E; DiMauro S
Ann Neurol; 1996 Jun; 39(6):789-95. PubMed ID: 8651651
[TBL] [Abstract][Full Text] [Related]
36. Novel demonstration of amyloid-β oligomers in sporadic inclusion-body myositis muscle fibers.
Nogalska A; D'Agostino C; Engel WK; Klein WL; Askanas V
Acta Neuropathol; 2010 Nov; 120(5):661-6. PubMed ID: 20711838
[TBL] [Abstract][Full Text] [Related]
37. Association of active extracellular signal-regulated protein kinase with paired helical filaments of inclusion-body myositis muscle suggests its role in inclusion-body myositis tau phosphorylation.
Wilczynski GM; Engel WK; Askanas V
Am J Pathol; 2000 Jun; 156(6):1835-40. PubMed ID: 10854206
[TBL] [Abstract][Full Text] [Related]
38. Immunolocalization of transcription factor NF-kappaB in inclusion-body myositis muscle and at normal human neuromuscular junctions.
Yang CC; Askanas V; Engel WK; Alvarez RB
Neurosci Lett; 1998 Sep; 254(2):77-80. PubMed ID: 9779924
[TBL] [Abstract][Full Text] [Related]
39. Inflammatory, immune, and viral aspects of inclusion-body myositis.
Dalakas MC
Neurology; 2006 Jan; 66(2 Suppl 1):S33-8. PubMed ID: 16432143
[TBL] [Abstract][Full Text] [Related]
40. Rimmed vacuoles with beta-amyloid and tau protein deposits in the muscle of children with hereditary myopathy.
Fidziańska A; Glinka Z
Acta Neuropathol; 2006 Aug; 112(2):185-93. PubMed ID: 16788822
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
